Abstract
Efforts towards international cooperation or harmonization can occur at varying levels – at the level of technical and scientific requirements, of dossier format and content, or of assessment and review practices. Three contrasting models for regional cooperation in drug regulation harmonization, the corporate, populist, and cooperative, are described and compared. Utilizing a specific case, drug stability testing requirements in Climatic Zone IV, the author explores each organizational model in action, reviews recent history of a key stability debate among harmonization initiatives from different climatic zones, discusses benefits and disadvantages seen in organizational models, and proposes the best practices approach to global harmonization efforts for the future.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Molzon, J.A. (2010). Current International Harmonization Efforts. In: Huynh-Ba, K. (eds) Pharmaceutical Stability Testing to Support Global Markets. Biotechnology: Pharmaceutical Aspects, vol XII. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0889-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0889-6_3
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0888-9
Online ISBN: 978-1-4419-0889-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)
